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morphic features is thought to be caused by chromosomal 
imbalances. Some of theses imbalances can be explained by 
gross chromosomal abnormalities, detected by convention-
al cytogenetic techniques such as GTG-banding. However, 
microdeletions and duplications are not detectable using 
those techniques, since the level of resolution is inadequate 
or unreliable for the detection of subtle copy number chang-
es involving chromosome segments of 5 Mb or less. 
  Subtelomeric rearrangements contribute significantly to 
unexplained dysmorphisms, malformations and/or MR 
and have been detected in approximately 5% of MR patients 
by fluorescent in situ hybridization (FISH) (Flint et al., 1995; 
Knight et al., 1999) analysis and multiplex ligation-depen-
dent probe amplification (MLPA) (Schouten et al., 2002; 
Koolen et al., 2005). As these techniques utilize designed 
   Abstract.  Chromosomal imbalances are the major cause 
of mental retardation (MR). Many of these imbalances are 
caused by submicroscopic deletions or duplications not de-
tected by conventional cytogenetic methods. Microarray-
based comparative genomic hybridization (array-CGH) is 
considered to be superior for the investigation of chromo-
somal aberrations in children with MR, and has been dem-
onstrated to improve the diagnostic detection rate of these 
small chromosomal abnormalities. In this study we used 
1 Mb genome-wide array-CGH to screen 48 children with 
MR and congenital malformations for submicroscopic 
chromosomal imbalances, where the underlying cause was 
unknown. All children were clinically investigated and sub-
telomere FISH analysis had been performed in all cases. 
Suspected microdeletion syndromes such as deletion 
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22q11.2, Williams-Beuren and Angelman syndromes were 
excluded before array-CGH analysis was performed. We 
identified de novo interstitial chromosomal imbalances in 
two patients (4%), and an interstitial deletion inherited 
from an affected mother in one patient (2%). In another two 
of the children (4%), suspected imbalances were detected 
but were also found in one of the non-affected parents. The 
yield of identified de novo alterations detected in this study 
is somewhat less than previously described, and might re-
flect the importance of which selection criterion of patients 
to be used before array-CGH analysis is performed. How-
ever, array-CGH proved to be a high-quality and reliable 
tool for genome-wide screening of MR patients of unknown 
etiology.    Copyright © 2007 S. Karger AG, Basel 
 Mental retardation (MR) is a variable and heterogeneous 
manifestation of central nervous system dysfunction, af-
fecting approximately 3% of the population. In a major part 
of these patients the etiology is unknown. In half of the cas-
es, MR with or without congenital malformations and dys-
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locus-specific probes they only return results specific for 
the assay, and therefore are not suitable for screening sub-
microscopic rearrangements on a genome-wide scale. On 
the other hand, microarray-based comparative genomic hy-
bridization (array-CGH) (Solinas-Toldo et al., 1997; Pinkel 
et al., 1998) enables genome-wide detection of DNA copy 
number alterations at high resolution, and has proven to 
have a major impact on research and diagnostics. In several 
studies array-CGH has shown to have great potential for the 
detection of submicroscopic chromosomal abnormalities in 
children with MR and dysmorphisms, which to date have 
escaped identification. Recent studies using such genome-
wide arrays to investigate patients with MR with and with-
out dysmorphic features have suggested a diagnostic yield 
of 10–25%, of which de novo findings count for approxi-
mately 10% (Vissers et al., 2003; Shaw-Smith et al., 2004; de 
Vries et al., 2005; Schoumans et al., 2005; Tyson et al., 2005; 
Menten et al., 2006; Rosenberg et al., 2006). 
    In this study we have used genome-wide array-CGH, 
with an average resolution of 1 Mb, to screen 48 children 
with idiopathic MR and dysmorphic features for chromo-
somal imbalances not detected by conventional cytogenetic 
and FISH techniques. 
  Materials  and  methods 
 Patient  material 
 48 patients with idiopathic MR (22 girls and 26 boys; age range 2 to 
15 years) were selected for array-CGH analysis. All patients were ex-
amined by a clinical geneticist. Apart from MR, patients also presented 
with additional features like congenital malformations and/or dysmor-
phism. All patients had at least one major and one minor or at least 
three minor malformations as previously described by Smith (1982). 
All patients had a normal karyotype from GTG-banding analysis at the 
+400-band level and subtelomeric rearrangements were excluded by 
FISH (Vysis). Genomic DNA was extracted from peripheral blood lym-
phocytes according to standard procedures. Patient samples were stud-
ied with the approval of the local Research Ethics Committee, Faculty 
of Medicine, Uppsala University.
  A r r a y - C G H  
 The BAC arrays used in this study had a resolution of 1 Mb and were 
produced as previously described (Fiegler et al., 2003). One microgram 
of genomic test and reference DNA were labeled and hybridized for 
16–18 h as previously described by Mantripragada et al. (2006). Dye 
swap experiments where performed on each case where a copy number 
change was suspected. A pool of sex-matched DNA from either eight 
normal male or female blood donors was used for the reference sam-
ples.
    Image and data analysis 
  Image acquisition was performed using a GenePix 4000B scanner 
(Axon Instruments Inc, Union City, CA). Images were quantified using 
SPOT software (Jain et al., 2002). Further data analysis was performed 
as previously described (Fiegler et al., 2003). In addition, clones listed 
as polymorphic in the Database of Genomic Variants (http://projects.
tcag.ca/variation/) were excluded from further analysis. To reduce 
false positive results, the SD was calculated for all autosomal controls. 
Clones displaying a test/reference ratio value exceeding   8  4 SD were 
considered as clinically significant and were subjected to further inves-
tigation (Vermeesch et al., 2005). Hybridizations where the SD exceed-
ed 0.1 were considered to have failed and the patient sample was rehy-
bridized. Clones which displayed copy number alterations in the dye 
swap experiments were confirmed by FISH or MLPA. Parents of the 
children displaying copy number changes were investigated for the or-
igin of the altered chromosomal region. Cases where chromosomal 
anomalies were detected were submitted to the DECIPHER database 
(http://www.sanger.ac.uk/Postgenomics/decipher) after gaining con-
sent from the parents of these children.
  F I S H  
 FISH validation experiments were performed in cases 1, 3 and 5 on 
metaphase spreads prepared from lymphocyte cultures of peripheral 
blood to confirm deletions identified by array-CGH analysis, as previ-
ously described (Wester et al., 2006). BAC clones were obtained from 
The Wellcome Trust Sanger Institute (Cambridge, UK). 
  M L PA  
  Confirmation of case 2 was carried out using the SALSA MLPA kit 
P064 MR1 (MRC-Holland, Amsterdam, Netherlands). In case 4, six 
specifically designed synthetic MLPA probes were used to cover the 
region of interest (Stern et al., 2004). MLPA reactions were performed 
as previously described (Schouten et al., 2002; Mantripragada et al., 
2006). One microliter of the amplification product was analyzed using 
an ABI 3130XL genetic analyzer (Applied Biosystems) using ROX-500 
(ABI) as an internal size standard. Analysis was performed with Gene-
Mapper software 3.7. Data analysis was performed in Microsoft Excel, 
where each peak area was divided by the sum of all control peak areas 
of that sample, followed by normalization to the ratio obtained by a 
control sample. 
  R e s u l t s  
 We analyzed 48 idiopathic MR patients with dysmorphic 
features by array-CGH, with an average resolution of 1 Mb. 
All patients had a normal karyotype when investigated by 
GTG-banding. Telomeric rearrangements had been exclud-
ed by subtelomere FISH. In total, five copy number chang-
es – three deletions and two duplications – were detected in 
five patients (10.4%). Three cases were considered as patho-
logical and of clinical significance (6%) and two cases were 
inherited from phenotypically normal parents (4%). The es-
timated maximum sizes of the genomic losses and gains 
ranged from 0.2 Mb (1 clone) to 6.9 Mb (8 clones). A descrip-
tion of the phenotypes of these patients and a summary of 
the results is presented in   Table 1  . In addition, single clone 
gain or loss was detected in numerous cases in this study. 
However, a majority of these were suspected to be polymor-
phic loci as they were either reported as copy number varia-
tions (CNV) in the Database of Genomic Variants (http://
projects.tcag.ca/variation/) or detected in several cases dis-
playing different phenotypes (  Table 2  ) and therefore disre-
garded. In four cases a deletion was detected in four clones 
at Yq11.223 (data not shown). This deleted region was 
deemed unlikely to contribute to the phenotype; hence these 
patients were excluded from further analysis.
  Case  reports   
    Case 1: 46,XY, arr cgh 20q13.12q13.13 (RP5-1049G16  ] 
RP5-1071L10)  !  1 dn  . This 6-year-old boy is the third child 
of healthy parents with two healthy siblings. He was born 
after a normal pregnancy at 37 weeks and six days gestation. 
His weight was 3.6 kg, length 51 cm and head circumference 
34 cm at birth. At the outset from birth he was muscularly   Cytogenet Genome Res 118:1–7 (2007)  3
hypertonic. He had severe failure to thrive and got a gastric 
tube at 5 months of age. At the age of 1 year severe MR was 
obvious with microcephaly. He started to walk at 2 years of 
age. He could not speak but gave good eye contact. At the 
age of 2 years and 3 months the following features were 
found: He was microcephalic with a head circumference
–3 SD. He had epicanthic folds, low set ears with thick down 
folded helixes, a hypoplastic nasal bridge, a short upturned 
nose with hypoplastic alas, a long philtrum, clinodactyly of 
fifth fingers bilaterally, bilateral syndactylies between the 
2 nd  and 3 rd  toes, a very small penis and scrotum, and reten-
tion testis. Chromosomal investigation, subtelomere FISH 
and Fragile-X analysis were all normal.
    As shown in   Fig. 1  A, an interstitial deletion spanning 
seven clones, RP5-1049G16 through RP5-1071L10, was de-
tected at 20q13.12  ]  q13.13, which could be verified by FISH 
using the two different BAC clones, RP5-1049G16 and RP5-
1071L10 located at the detected breakpoints (  Fig. 1  B, and 
data not shown). This deletion could not be detected in the 
parents and was considered de novo and consequently of 
clinical significance. A fraction of this region, covering 
RP5-1049G16, has been reported in the Database of Genom-
ic Variants (Tuzun et al., 2005; McCarroll et al., 2006; Redon 
et al., 2006).
    Case 2: 46,XX, arr cgh 17p12p11.2 (RP11-219A15  ]  RP11-
121A13)  !  3 dn  . This 6-year- and 6-month-old girl has one 
healthy older sibling and non-consanguineous parents. She 
was born after a normal pregnancy in a normal delivery. 
Her birth weight was 2.9 kg. She had severe failure to thrive 
and was fed from birth by tube. At one year of age she was 
growth retarded (–3.0 SD) and got a gastric tube which al-
lowed her to grow and her height at 4.5 years of age was 1.0 
m (–1.0 SD). From the age of 1 year it was obvious that she 
was mentally retarded. She started to walk and speak the 
first words at two years of age. At 5.5 years of age she had 
the following features: She was very thin, her face was tri-
angular, she had hypertelorism with down-slanted palpe-
bral fissures, a divergent strabismus, and long eye lashes. 
Brainstem audiometrics, eye examinations as well as a CT 
scan of the brain were all normal. Chromosome and sub-
telomere FISH analyses were normal. 
    Array-CGH analysis revealed a duplication spanning 
eight clones, RP11-219A15 through RP11-121A13, at 17p11.2 
(  Fig. 1  C). This duplication overlaps with the previously de-
scribed dup(17)(p11.2p11.2) syndrome (Potocki et al., 2000). 
The duplication was verified by six different probes in
the SALSA MLPA kit P064 MR1 ( Fig. 1 D; ID 26–31), lo cated 
in the critical region of the Smith-Magenis and 
dup(17)(p11.2p11.2) syndrome. By the same method this du-
plication could not be detected in the parents. Consequent-
ly this duplication was considered de novo and presumed to 
be the cause of the phenotype of this girl.
   Case 3: 46,XX, arr cgh 4q28.3q31.21 (RP11-63M2  ]  RP11-
69O1)  !  1 mat  . This 8-year-old girl was born after a normal 
pregnancy at 39 weeks gestation. Her weight was 2.98 kg at 
birth. From 5 months of age she had failure to thrive and she 
received a gastrostomy at 3 years of age. She was moderate 
mentally and growth retarded (–2 SD). She was severely hy-
peropic (+7 dioptres) and got eye glasses at 3 years of age. At 
5 years of age she had the following features: short stature, 
frontal bossing, short neck and hypertelorism. The follow-
ing investigations gave normal results: hearing investiga-
tion, CT scan of the brain, electromyography and muscle 
Table 1. Summary of phenotypes and copy number changes detected by array-CGH
Case Age Karyo-
type
Phenotypea Array-CGH resultsb Confirma-
tion method
Origin Estimated size (Mb)
min. / max. 
1 6 46,XY severe MR, failure to thrive, microcephaly,
micropenis, retentio testis, dysmorphic features
del of 7 clones at 
20q13.12]q13.13
FISH de novo 3.2 / 5.1
2 6 46,XX severe growth and MR, failure to thrive, 
dysmorphic features
dup of 8 clones at 
17p12]p11.2
MLPA de novo 3.6 / 6.9
3 8 46,XX moderate MR, severe growth retardation,
failure to thrive, hyperopia, dysmorphic features
del of 4 clones at 
4q28.3]q31.21
FISH maternally inherited, 
mother with MR and 
similar dysmorphism
3.8 / 6.9
4 6 46,XY severe MR, failure to thrive, dysmorphic features dup of 1 clone at 2p25.3 MLPA maternally inherited 0.2 / 0.9
5 3 46,XY moderate MR, severe growth retardation,
ventricular septal defect, cleft lip and palate,
inguinal hernia, a benign facial histiocytoma, 
hyperopia, dysmorphic features
del of 1 clone at 7p22.2 FISH paternally inherited 0.09 / 0.2
a  MR = mental retardation.
b  del = deletion; dup = duplication.
Table 2. Clone list with suspected poly-
morphic loci
Chromosome Clone ID Gain Loss
19 CTC-251H24 8 3
19 CTC-260F20 9 3
19 CTC-325L16 1 1Cytogenet Genome Res 118:1–7 (2007) 4
biopsy (because of elevated serum levels of CK), chromo-
somal analysis, subtelomere FISH investigation, and a meth-
ylation test for Prader-Willi syndrome. 
    A deletion spanning four clones, RP11-63M2 through 
RP11-69O1, at 4q28.3  ]  q31.21 was identified by array-
CGH, which could be verified by FISH analysis ( Fig. 1 E and 
F). An identical deletion was detected by array-CGH in the 
mother, who has a mild MR, severe congenital unilateral 
hearing deficit, impaired social interaction with severe 
speech problems and with a phenotype similar to her daugh-
ter. Considering this information the detected deletion is 
considered as pathogenic. One part of this region, spanning 
RP11-425J20, is reported in the Database of Genomic Vari-
ants (Redon et al., 2006).
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   Fig.  1.  Array-CGH profiles of detected chromosomal abnormalities 
and confirmatory FISH and MLPA analysis. The array-CGH profiles 
of DNA derived from three cases versus sex matched reference DNA 
are shown in panels  A ,  C  and  E . Panels  B  and  F  show the corresponding 
FISH analysis for each patient, and Panel  D  the corresponding MLPA 
analysis. The x-axis displays the distance in Mb along the chromosome 
from the p to the q telomere, and the y-axis the log2 ratios at each locus. 
The red lines indicate the threshold for a deletion or a duplica-
tion (  8   4   SD). ( A ) Array-CGH profile of a 7-clone deletion at 20q13.12  ]
  q13.13 in case 1. ( B ) Confirmatory FISH analysis of case 1 using BAC 
clone RP5-1049G16 (red) located in the deletion and control clone RP5-
1054C24 (green). ( C ) Array-CGH profile of an 8-clone duplication at 
17p12  ]  p11.2 in case 2. ( D ) Profile from confirmatory MLPA analysis 
of case 2, displaying a duplication of six probes (ID 26 through 31) lo-
cated in the critical region of dup(17)(p11.2p11.2) syndrome. ID 1–25 
and 32–42 display chromosomal locations associated with other syn-
dromes. ( E ) Array-CGH profile of a 4-clone deletion at 4q28.3  ]  q31.21 
in case 3. ( F ) Confirmatory FISH analysis of case 3 using BAC clone 
RP11-63M2 (red) located in the deletion and control clone RP11-177L7 
(green).   Cytogenet Genome Res 118:1–7 (2007)  5
    Case 4: 46,XY, arr cgh 2p25.3 (RP11-168K7)  !  3 mat  . This 
is a 6-year-old boy of healthy non-consanguineous parents. 
He was born in a normal delivery after a 40-week normal 
pregnancy. His weight was 4.24 kg and length was 50 cm at 
birth. He had severe failure to thrive and received a gastros-
tomy before the age of six months. He had an abnormal mo-
tor development with jerky movements. He had a pathologi-
cal electroencephalogram but no convulsions. He has severe 
MR and could not sit without support at 2 years of age and 
still has no spoken language. At 2 years of age he had the fol-
lowing features: flat occipital region, high vaulted and nar-
row palate, dysmorphic ears, a flat philtrum, epicanthic folds, 
speckled iris, and broad thumbs. Brain scan (MRT) and an 
examination of vision and hearing revealed normal results. 
Chromosomal and subtelomere FISH analyses were normal. 
Angelman and Williams-Beuren syndromes were excluded 
by methylation test and FISH analysis, respectively.
    Array-CGH analysis detected a single clone duplication 
of RP11-168K7 at 2p25.3. The duplication was verified with 
six specifically designed synthetic MLPA probes, three for 
each of the two genes  PXDN  and  MYT1L , situated within 
the duplicated BAC clone (data not shown). However, as an 
identical duplication was detected by array-CGH and MLPA 
in the phenotypically normal mother, this aberration was 
considered to be benign. 
   Case 5: 46,XY, arr cgh 7p22.2 (RP11-348A21)  !  1 pat . This 
is the first child of Turkish parents who are double first 
cousins. The boy was born at full term after a normal preg-
nancy. His weight was 3.0 kg, length 48 cm and head cir-
cumference 37 cm at birth. He had severe postnatal feeding 
difficulties and received a gastric tube at the age of 1 year. 
He was severely growth retarded at the age of 2 years and 4 
months with a weight of 9.6 kg (–4 SD) and a height of 80 
cm (–4 SD). He had a ventricular septal defect, bilateral re-
tentio testis, and bilateral cleft lip and palate. He had an in-
guinal hernia which was surgically corrected at eight months 
of age. He was bilaterally hyperopic and requires eye glasses 
(+5 dioptres). At 9 months of age he was operated upon be-
cause a benign histiocytoma on his right chin. At the age of 
2 years and 4 months he had the following features: He is 
mildly mentally retarded and has just learned to walk and 
can speak a few words. His ears are big. He has hyper-
telorism and bilateral ptosis, his eye lashes are long and the 
lateral parts of the palpebral fissures are inverted. The nasal 
bridge is high and broad. Kabuki syndrome was suspected, 
but his finger pads as well as nails were normal. Chromo-
somal and subtelomere FISH analyses were both normal.
    A single clone deletion, RP11-348A21, was detected at 
7p22.2 by array-CGH and was further verified by FISH. 
However, as a deletion of the same size was detected by ar-
ray-CGH in the phenotypically normal father, this aberra-
tion was considered benign. Recently a deletion polymor-
phism was identified just upstream of this BAC clone, RP11-
348A21, involving the same gene,  SDK1  (Conrad et al., 2006; 
McCarroll et al., 2006; Redon et al., 2006). Consequently the 
present deletion is most likely a deletion polymorphism. 
Since the parents are related an autosomal recessive syn-
drome might be suspected.
  Discussion 
  The diagnostic tools for patients with dysmorphic fea-
tures, malformations and/or MR have been exhausted in 
many cases. Consequently, the diagnosis and the underly-
ing genetic lesions remain unclear. With the long-term goal 
to identify the genetic basis behind most constitutional phe-
notypes associated with chromosomal imbalances, the es-
tablishment of array-CGH analysis is necessary. The array-
CGH technique has demonstrated the potential to clarify 
unexplained phenotypes at the genomic level and when ex-
tended, to identify candidate gene regions and candidate 
genes behind any condition with alterations in gene copy 
number.
  Array-CGH has already been shown by several studies to 
be a reliable tool for genome-wide detection of copy number 
changes in MR patients (Vissers et al., 2003; Shaw-Smith et 
al., 2004; de Vries et al., 2005; Schoumans et al., 2005; Tyson 
et al., 2005; Menten et al., 2006; Rosenberg et al., 2006). 
    In this study we screened 48 patients with MR and dys-
morphic features. All patients had a normal karyotype by 
standard cytogenetic chromosomal banding and subtelo-
mere FISH analysis. We detected pathogenic copy number 
changes in three patients (6%), of which two were de novo. 
All chromosomal imbalances contain genes annotated by 
Ensembl. Case 1 had a deletion 20q13.12  ]  q13.13. No previ-
ous patient has been described with an interstitial deletion 
of that segment. One patient with severe MR and a terminal 
deletion del(20)(q13  ]  qter) is reported (Fraisse et al., 1982). 
That boy had a hypoplastic nasal bridge and a long philtrum 
similar to the present boy. Case 2 was identified as the new-
ly reported dup( 17)(p 11.2p 11.2) syndrome (Potocki et al., 
2000). This girl has a similar phenotype compared to other 
reported cases with a triangular face, down-slanted palpe-
bral fissures and growth- and MR (Magenis et al., 1986; 
Kozma et al., 1991; Potocki et al., 2000). Thus, cases 1 and 2 
seem to fit phenotypically with previously described pa-
tients with similar chromosomal abnormalities. The girl in 
case 3 has a 6.9-Mb deletion on 4q28.3  ]  q31.21 inherited 
from the mother with congenital unilateral hearing deficit, 
which is not present in the daughter. Thirteen genes are lo-
cated within the deleted region, of which none has been as-
sociated with deafness. In addition, the mother has a mild 
MR, impaired social interaction and verbal communica-
tion, and has a phenotype similar to her daughter. Hence, 
the detected deletion is a good candidate to cause the phe-
notype of this girl. Unfortunately DNA from the grandpar-
ents is not available, and therefore it is not possible to deter-
mine the origin of the detected deletion. An overlapping 
deletion of 11 Mb is reported in the DECIPHER database. 
This deletion is de novo and considerably larger in size. The 
phenotypes of these two patients do not overlap (Laurence 
Colleaux, personal communication).
    In two patients (4%) copy number changes inherited 
from phenotypically normal parents were detected. It is pre-
sumed that inherited aberrations do not contribute to a di-
agnosed phenotype. It is difficult to interpret whether these 
anomalies are of any clinical significance, or if they contrib-Cytogenet Genome Res 118:1–7 (2007) 6
ute to the phenotype by other mechanisms such as non-pen-
etrance, which has been described in 22q11.2 microdeletion 
and -duplication syndromes (Wilson et al., 1992; Yobb et al., 
2005 ) , o r b y im p rin ting. H en ce, th ese benign varia ti o ns 
need further genotypic and phenotypic evaluation and it is 
therefore important to report them to databases such as 
 DECIPHER  (http://www.sanger.ac.uk/Postgenomics/deci-
pher) to allow comparisons to be drawn with other clinical 
cases and to generate more insight into the plasticity of the 
human genome. Hence, as can be concluded from this study 
and others (Shaw-Smith et al., 2004; de Vries et al., 2005; 
Menten et al., 2006; Rosenberg et al., 2006), it appears that 
confirmation of all array-CGH findings with the parents of 
the respective child is required, as approximately half of the 
detected findings appear to be inherited from a phenotypi-
cally normal parent.
    The two inherited aberrations were checked against the 
DECIPHER database where copy number changes were de-
tected at the same chromosomal region in both cases. A 2.7-
Mb de novo deletion has been reported to the DECIPHER 
database in the same chromosomal region as detected in 
case 4, 2p25.3. The detected aberration in the present case 
however is a 0.9-Mb duplication inherited from the mother. 
The phenotypes of these two patients do not overlap (Rose-
mary Ekong, personal communication). A 3.6-Mb deletion 
was reported in the DECIPHER database in the same region 
as the 0.2-Mb deletion detected in case 5. However, this re-
ported deletion was de novo and the phenotypes of the two 
cases do not overlap (Farah Zahir and Jan Friedman, per-
sonal communication) (Friedman et al., 2006). 
  In a recent literature review of all published 1-Mb screen-
ing studies of MR patients the yield was reported to be 8.8% 
(Menten et al., 2006). The detection rate of de novo findings 
in our study is somewhat lower (6%). The lower yield de-
tected in our study might be explained by the fact that the 
patient material was not selected according to the checklist 
developed by de Vries   et al. (2001), but according to the ma-
jor and minor anomalies described by Smith (1982), com-
monly used by clinicians. This might suggest that to gain a 
higher rate of detection, the checklist of de Vries might be 
more suitable as a selection criterion for array-CGH analy-
sis. However, array-CGH and oligoarrays today are the only 
diagnostic tools for high-resolution genome scanning, to 
detect submicroscopic aberrations in these patients. For 
that reason, all MR patients with or without congenital mal-
formations and/or dysmorphism might benefit from array-
CGH.
    For clinical settings, an alternative to genome-wide ar-
ray-CGH could be the targeted genomic microarrays (Shaf-
fer et al., 2006). Compared to other studies the detection 
rate of these arrays is lower, 5.6% compared to 8.8% (Men-
ten et al., 2006; Shaffer et al., 2006), but they have the ad-
vantage of less polymorphic findings. However, they will 
fail to detect patients with rearrangements not previously 
described like case 1 and 3 in the present study. In that sense, 
a 1-Mb genome-wide array with a higher density of large 
insert clones in known microdeletion and duplication and 
telomere regions might be more suitable. The detection rate 
in our study is comparable to the targeted arrays but lower 
than described in other studies. This might be explained by 
the fact that our cohort of patients had already been exclud-
ed from patients with telomeric rearrangements and known 
syndromes associated with MR like Prader-Willi, monoso-
my 1p36 and DiGeorge. Also the number of patients in this 
study is considerably lower than in some other studies, 
which affects the statistical significance. Nonetheless, ar-
ray-CGH still proved to be a high-quality tool for genome-
wide screening of MR patients with dysmorphic features 
where the etiology is unknown.
    Clarification of the genetic profile generated by array-
CGH analysis may result in detailed follow-ups and, in the 
long-term, a better overall outcome for these patients. The 
short-term perspective allows for family counseling and 
prenatal diagnosis as well as for the identification and func-
tional analysis of candidate gene regions/genes underlying 
the condition.  
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